Evidence map›Paper›PMID 34341566›Full record

ReviewNature reviews. Microbiology2022

Physiological limitations and opportunities in microbial metabolic engineering.

José Montaño López, Lisset Duran, José L Avalos

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 168 citations in OpenAlex.

  1. Article
  2. Minicells derived fromApplied and environmental microbiology · 2026
    Article
  3. Article
  4. Engineering of plant-derived P450scc forSynthetic and systems biotechnology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Metabolic engineering ofSynthetic and systems biotechnology · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

José Montaño LópezDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.
Lisset DuranDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.
José L AvalosDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA. javalos@princeton.edu.ORCID 0000-0002-7209-4208
Princeton University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic engineering can have a pivotal role in increasing the environmental sustainability of the transportation and chemical manufacturing sectors. The field has already developed engineered microorganisms that are currently being used in industrial-scale processes. However, it is often challenging to achieve the titres, yields and productivities required for commercial viability. The efficiency of microbial chemical production is usually dependent on the physiological traits of the host organism, which may either impose limitations on engineered biosynthetic pathways or, conversely, boost their performance. In this Review, we discuss different aspects of microbial physiology that often create obstacles for metabolic engineering, and present solutions to overcome them. We also describe various instances in which natural or engineered physiological traits in host organisms have been harnessed to benefit engineered metabolic pathways for chemical production.

Indexed as

Metabolic Networks and PathwaysBacteriaBacterial Physiological PhenomenaBiosynthetic PathwaysIndustrial MicrobiologyMetabolic Engineering

Identifiers

PMID34341566
OpenAlexW3187214926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.